| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgement to Referees
|
|
|
2018
|
18 |
4 |
p. 251-253
|
artikel
|
| 2 |
Efficacy and Safety of Budesonide in the Treatment of Eosinophilic Esophagitis: Updated Systematic Review and Meta-Analysis of Randomized and Non-Randomized Studies
|
Rawla, Prashanth
|
|
2018
|
18 |
4 |
p. 259-269
|
artikel
|
| 3 |
Isavuconazole Kinetic Exploration for Clinical Practice
|
Darnaud, Léa
|
|
2018
|
18 |
4 |
p. 317-321
|
artikel
|
| 4 |
Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
|
Gardiner, Kyle M.
|
|
2018
|
18 |
4 |
p. 271-282
|
artikel
|
| 5 |
Post Hoc Analysis of the CONFIDENCE II, PROTECT I, SHAKE THE HABIT I and SHAKE THE HABIT II Observational Studies in Mild to Moderate Hypertensive Patients Treated with Perindopril and Atorvastatin Concomitantly
|
Sampalis, John S.
|
|
2018
|
18 |
4 |
p. 283-293
|
artikel
|
| 6 |
Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study
|
Durães, André R.
|
|
2018
|
18 |
4 |
p. 303-308
|
artikel
|
| 7 |
Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody–Drug Conjugate
|
Lashari, Bilal H.
|
|
2018
|
18 |
4 |
p. 255-258
|
artikel
|
| 8 |
Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm Trial
|
Slopis, John M.
|
|
2018
|
18 |
4 |
p. 295-302
|
artikel
|
| 9 |
Two Glucose-Lowering Mechanisms of Canagliflozin Depending on Body Weight Changes in Drug-Naïve Subjects with Type 2 Diabetes
|
Kutoh, Eiji
|
|
2018
|
18 |
4 |
p. 309-315
|
artikel
|
Tijdschrift beschrijving